Versatope Therapeutics
Dr. DeLisa is a Co-Founder of and the William L. Lewis Professor of Engineering at Cornell University. His research team focuses on the molecular machines of protein biosynthesis both as a toolbox for the discovery, design and manufacturing of biopharmaceuticals and as targets for reprogramming cellular physiology.
This person is not in the org chart
This person is not in any offices
Versatope Therapeutics
Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.